June 28, 2011 5:32 pm Breast Cancer Patient Beg FDA to Keep Avastin on the Market The FDA is holding two days of hearings about whether approval of the blockbuster breast cancer drug Avastin should be revoked. US & World Videos 3:32 USC, UCLA students navigate end of the year protests 3:26 Confrontations occur at UCLA campus amid ongoing protests 2:44 Tommy Trojan statue cleaned after vandalism 0:23 LA County sheriff's deputy dies on duty at station 0:57 Fights break out at UCLA between pro-Palestinian, pro-Israel supporters
